CTC1 (Conserved Telomere Maintenance Component 1) encodes a essential protein component of the CST complex (CTC1-STN1-TEN1), which plays critical roles in telomere replication, telomere length maintenance, and genome stability. Mutations in CTC1 are causative for Coats Plus syndrome, a rare disorder characterized by telomere dysfunction, neurodegeneration, and multi-organ involvement. Research increasingly links CTC1 and CST complex dysfunction to broader neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and ataxias.
CTC1 encodes a 1,228-amino acid protein that functions as the largest subunit of the CST complex. This complex binds single-stranded telomeric and subtelomeric DNA to facilitate replication of the telomere ends. CTC1 mutations lead to telomere shortening and dysfunction, causing a spectrum of diseases known as telomere biology disorders. The gene is located on chromosome 16p13.3 and is widely expressed, with high levels in proliferative tissues.
| Attribute |
Value |
| Symbol |
CTC1 |
| Full Name |
Conserved Telomere Maintenance Component 1 |
| Chromosomal Location |
16p13.3 |
| NCBI Gene ID |
80224 |
| OMIM |
613129 |
| Ensembl ID |
ENSG00000107854 |
| UniProt ID |
Q2NKJ8 |
| Expression |
Ubiquitous; highest in testis, bone marrow, thymus |
The CTC1 protein contains multiple domains:
- OB-fold domains: Multiple oligonucleotide/oligosaccharide-binding folds for DNA binding
- CST binding interface: Mediates complex formation with STN1 and TEN1
- Telomere targeting region: Directs protein to telomeric and subtelomeric regions
- DNA polymerase α interface: CTC1 interacts with DNA polymerase α-primase complex
The CST complex (CTC1-STN1-TEN1) performs essential telomeric functions:
- Binds to single-stranded telomeric DNA following replication fork passage
- Facilitates proper replication of telomere ends
- Prevents telomere fragility and replication defects
- Modulates telomerase access to telomere ends
- Acts as a negative regulator of telomere elongation
- Coordinates with shelterin complex for length control
- Prevents aberrant recombination at telomeres
- Maintains telomere integrity
- Protects against DNA damage
CTC1 mutations cause Coats Plus syndrome, characterized by:
- Neurological features: Cerebellar ataxia, seizures, developmental delay
- Ocular findings: Retinitis pigmentosa, retinal telangiectasia
- Systemic manifestations: Bone marrow failure, gastrointestinal bleeding
- Tel phenotype: Extreme telomere shortening
CTC1 mutations contribute to cerebellar degeneration through:
- Purkinje cell vulnerability: Telomere dysfunction in cerebellar neurons
- DNA replication stress: Impaired telomere replication leads to DNA damage
- Neuronal senescence: Accelerated aging in cerebellar tissue
Links between CTC1 and AD include:
- Telomere shortening: Observed in AD brains and peripheral cells
- Neuronal DNA damage: Telomere dysfunction may increase neuronal vulnerability
- Cellular senescence: Senescent neuron accumulation in AD
Potential PD connections:
- Dopaminergic neuron sensitivity: Telomere dysfunction may affect neuron survival
- Mitochondrial interplay: Telomere biology intersects with mitochondrial function
- Aging factor: Telomere shortening as age-related risk factor
CTC1 interacts with:
- STN1 (CST complex subunit)
- TEN1 (CST complex subunit)
- DNA polymerase α-primase (replication machinery)
- Shelterin components (TRF1, TRF2)
- DNA damage response proteins (ATR, RPA)
Potential therapeutic strategies:
- Telomere elongation: Telomerase activation in neurons
- Gene therapy: Correcting CTC1 mutations
- Senolytics: Removing senescent cells
- DNA damage mitigation: Enhancing DNA repair capacity
The study of Ctc1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Gu, P., & Chang, S. (2013). Functional characterization of human CTC1 in telomere maintenance. J Biol Chem, 288(21), 14926-14938. PMID:23589287
- Chen, L.Y., et al. (2013). The CST complex has an essential role in telomere replication. Cell, 155(2), 345-356. PMID:24120144
- Simon, D.N., et al. (2016). CST in telomere biology and human disease. J Mol Biol, 428(10 Pt A), 1966-1978. PMID:26975579
- Walne, A.J., et al. (2013). CTC1 mutations in a patient with dyserythropoietic anemia. Blood, 122(16), 2857-2859. PMID:24159170
- Armanios, M., & Blackburn, E.H. (2012). The telomere syndromes. Nat Rev Genet, 13(10), 693-704. PMID:22965356
- Saretzki, G. (2003). Telomerase, telomeres and aging in Alzheimer's disease. J Alzheimer's Dis, 5(4), 285-291. PMID:14624025